-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Uk+GxkSm+efUPT+wwYcv/Wbe6drvz211zMJQstd/9rMOTXXjoINNihIxQYah72sl
 gn3J1B3Jt3ouR2WqXxvoPQ==

<SEC-DOCUMENT>0001193125-04-167052.txt : 20041005
<SEC-HEADER>0001193125-04-167052.hdr.sgml : 20041005
<ACCEPTANCE-DATETIME>20041005172925
ACCESSION NUMBER:		0001193125-04-167052
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20041005
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20041005
DATE AS OF CHANGE:		20041005

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYO CELL INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000862692
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SERVICES, NEC [8900]
		IRS NUMBER:				223023093
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23386
		FILM NUMBER:		041066846

	BUSINESS ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
		BUSINESS PHONE:		7277230333

	MAIL ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG. B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="3"><B>Pursuant to Section 13 or 15(d) of </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>the Securities Exchange Act of 1934 </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Date of Report (Date of earliest event reported): October 5, 2004
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>CRYO-CELL International, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact
name of registrant as specified in its charter) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>0-23386</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>22-3023093</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>3165 McMullen Booth Road, Bldg. B, Clearwater, FL</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>33761</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Registrant&#146;s
telephone number, including area code: (727) 450-8000 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="2"><B>Not applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report) </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item 2.02. Results of Operations and Financial Condition. </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">The information in this Item is furnished to, but not filed with, the
Securities and Exchange Commission (the &#147;Commission&#148;) solely under Item 12 of Form 8-K, &#147;Results of Operations and Financial Condition.&#148; </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">On October 4, 2004, CRYO-CELL International, Inc. issued a press release that included financial information for the nine months ended August 31, 2004. A
copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2"><B>Item 9.01. Financial Statements and Exhibits. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><U>Exhibits<B></B></U> </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Press Release dated October 4, 2004 </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">-2- </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">CRYO-CELL INTERNATIONAL, INC.</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">(Registrant)</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Date: October 5, 2004</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">/s/ Jill M. Taymans</FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Title:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Vice President, Finance</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">-3- </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><U>EXHIBIT INDEX</U> </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>EXHIBIT</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>NUMBER</B></FONT></P><HR WIDTH="56"
SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>EXHIBIT</B></FONT></P><HR WIDTH="53" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:2.50em; text-indent:-2.50em"><FONT FACE="Times New Roman" SIZE="2">Press&nbsp;&nbsp;Release dated October 4, 2004.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">-4- </FONT></P>

</BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>EXHIBIT 99.1 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px">

<IMG SRC="g7804178041jpeg.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="42%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2"><B>For Immediate Release</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2"><B>Contact:</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2"><B>Todd Atenhan</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">727-450-8000</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">727-723-0444 (Fax)</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">investor.relations@CRYO-CELL.com</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>CRYO-CELL
INTERNATIONAL, INC. REPORTS RESULTS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>FOR THIRD QUARTER 2004 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Company Reports Net Income, Increased Revenues, Higher Gross Margins, </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>and Strong Cash Position </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B><I>TREND OF SOLID PERFORMANCE CONTINUES AS STRATEGIC PLAN TO ACHIEVE TRANSFORMATIONAL SUCCESS REMAINS WELL ON TRACK </I></B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Clearwater, FL &#150; October 4, 2004 </B>- CRYO-CELL International, Inc. (OTC Bulletin
Board Symbol: CCEL) (the &#147;Company&#148;) today announced consolidated revenues of approximately $3.2 million for the third quarter ended August 31, 2004, compared to approximately $2.0 million for the third quarter of fiscal 2003. The 59%
revenue increase over the same 2003 period is primarily attributable to an increase in recurring annual storage revenues and the effects of successfully implemented price increases during 2004 for newly enrolling clients. </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Net income in the third quarter of 2004 was approximately $1.9 million,
compared to a net loss of approximately $889,000 in the third quarter of 2003. Net income in the third quarter of 2004 included approximately $1.6 million from the reversal of all prior accruals with respect to the PharmaStem litigation, as a result
of the favorable ruling by the Court on post trial motions in that case. The remaining approximately $300,000 in net income was principally due to increased revenues and gross profits compared to 2003 levels. The Company&#146;s gross margin
increased to 73% of revenue in the third quarter of 2004 from 68% in the 2003 period. The gross margin improvement is a result of increased revenues due to price increases combined with relatively fixed costs as described above. As of August 31,
2004, the Company had $4.2 million in available cash and cash equivalents and no long-term debt. Also, as a result of the Court&#146;s favorable ruling in the PharmaStem litigation, the Company will obtain approximately $958,000 that was being held
in an escrow account per the original jury verdict. The Company expects the monies to be returned during the fourth quarter 2004. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">For the nine-month period ended August 31, 2004, the Company&#146;s revenues were approximately $9.0 million, compared to approximately $5.1 million for
the nine-month period ended August 31, 2003. The 77% revenue increase over the same 2003 period is primarily attributable to an increase in recurring annual storage revenues and the effects of successfully implemented price increases during 2004 for
newly enrolling clients. Net income for the nine-month period ended August 31, 2004 was approximately $2.7 million, compared to a net loss of </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">approximately $3.1 million in the 2003 period. As described above, net income for the 2004 period included $1.6 million
from the reversal of all prior accruals related to the PharmaStem litigation during the third quarter of 2004. The Company&#146;s remaining $1.1 million in net income was due to increased revenues as described above. The Company&#146;s gross margin
increased to 75% of revenue in the first nine months of 2004 from 62% in the 2003 period. The 13% gross margin improvement is a result of increased revenues due to price increases combined with relatively fixed costs as described above. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">&#147;We are very pleased with CRYO-CELL&#146;s continuing solid
performance throughout the third quarter and with our progress towards operational expansion and strategic market development,&#148; commented Mercedes Walton, Chairman and interim CEO. &#147;We are also encouraged by the recent favorable Court
ruling on post trial motions in the PharmaStem matter which determined that the jury&#146;s earlier verdict of infringement was, according to the Court&#146;s opinion, &#147;against the great weight of the evidence&#148;. This ruling is a positive
development for CRYO-CELL, the practitioner community and the families we serve and contributed positively to third quarter results with the reversal of approximately $1.6 million in prior accruals. As a result of this ruling, we expect
approximately $958,000 held in escrow to be returned to the Company in the fourth quarter. Ultimately, we expect both of the patents will be invalidated, and PharmaStem&#146;s present claims will be unenforceable.&#148; </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">&#147;The Company has also made significant progress in controlling our costs
on a year-to-date basis. Notwithstanding anticipated quarterly fluctuations due to planned increases in marketing and sales spending, along with pending litigation matters, we expect to continue to tightly manage expense while maximizing shareholder
profitability.&#148; Ms. Walton continued, &#147;CRYO-CELL is well on track with our strategic plan to achieve transformational success.&#148; </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">About CRYO-CELL International, Inc. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Based in Clearwater, Florida, CRYO-CELL is the world&#146;s largest U-Cord</FONT><FONT FACE="Times New Roman" SIZE="1"
COLOR="#000000"><SUP><SUP>&reg;</SUP><SUP></SUP></SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> stem cell banking firm, offering high-quality cord blood preservation exclusively for the benefit of newborn babies and possibly
other members of their family. CRYO-CELL is accredited by the American Association of Blood Banks (AABB). </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">CRYO-CELL is a publicly traded company. OTC Bulletin Board Symbol CCEL. Expectant parents or healthcare professionals may call 1-800-STOR-CELL (1-800-786-7235) or visit <U>www.CRYO-CELL.com</U>. </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Forward-Looking Statement </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Statements wherein the terms &#147;believes&#148;, &#147;intends&#148;, &#147;projects&#148;
or &#147;expects&#148; as used are intended to reflect &#147;forward-looking statements&#148; of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ
materially from the results anticipated in such forward-looking statements or paragraphs, many of which are outside the control of the Company. These uncertainties and other factors include any adverse effect or limitations caused by any
governmental regulations, proceedings or actions, foreign and domestic; any continued or increased losses, or any inability to obtain acceptable </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">financing, where desirable in the future, in connection with our operating or growth plans; any increased competition in
our business; any decrease or slowdown in the number of people seeking to store umbilical cord blood stem cells or decrease in the number of people paying annual storage fees; the effect of any future reduced cash position and future inability to
access borrowings; any adverse impacts on our revenue or operating margins due to the costs associated with increased growth in our business, including the possibility of unanticipated costs relating to the move into our new facility or the
operation of the facility; any adverse developments impacting our continued relationship with and success of our licensees, foreign affiliates or investments in, or relationships with, foreign companies; any inability to achieve increases in revenue
or earnings from umbilical cord blood stem cell storage; any future inability to substantially achieve the objectives expected from the successful implementation of our strategy; any decline in public market interest in the Company&#146;s business
sector; any added requirements imposed on us by new laws or SEC regulations and costs thereof; any technological breakthrough or medical breakthrough that would render the Company&#146;s business of stem cell preservation obsolete; any material
failure or malfunction in our storage facilities; any natural disaster such as a tornado, other disaster (fire) or act of terrorism that adversely affects stored specimens; the potential impact of negative market influences on the Company&#146;s
portfolio of cash, cash equivalents and marketable securities; the costs associated with defending or prosecuting litigation matters and any material adverse result from such matters; decreases in asset valuations; any continued negative effect from
adverse publicity in the past year regarding the Company&#146;s business operations; any new technology rendering the Company&#146;s patented equipment or business obsolete; any performance failures related to the Company&#146;s equipment or
operations; any negative consequences resulting from deriving, shipping and storing specimens at a second location; any negative effect from the filed class action shareholder lawsuits; and other risks and uncertainties. The foregoing list is not
exhaustive, and the Company disclaims any obligations to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements. Readers should carefully review the risk factors described in other
documents the Company files from time to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-KSB, Quarterly Reports on Form 10-QSB and any Current Reports on Form 8-K filed by the Company. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">-END- </FONT></P>
</BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g7804178041jpeg.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g7804178041jpeg.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`-@(N`P$1``(1`0,1`?_$`+(``0`!`P4!`0``````
M```````'!@@)`@0%"@L#`0$!``("`P$!``````````````0%`P8"!P@!"1``
M``8"`0(%`@,'!`(#`````@,$!08'`0@`$0D2$Q05%A<8(9=8,2(C)"77"B:W
M&3E!=C+6>!$``@$$`0,"`P4$!@@%!0```0(#$1($!0`A$P8B%#$5!T$R(U46
MD4(SE%&STR34-F%QH;%20X.TTG,T="5RDE-C%__:``P#`0`"$0,1`#\`ZIHQ
MB,$(8Q"&,8LC&,><B$,0LYR(0A9SG(A"SGKG.?QSGGZ(`!0%4`*!T'/"LDDD
MTC33,SRNQ+,2222:DDGJ23U)/4GGYS[SAS)=CM`=Q`6L0-N@ZX2H=.F,()>`
MX*IJS-108QN]W+G6*_\`6_+110;9G"G"G"7(LILX.\'D_P`3FH2>>>)1[M?'
MSF(=F7*$6N%20$CMM(5$=]0!1687,$)ON4;W%].?)IM(N]ACC:!HA(L88F5D
M/4$*%*DE3>%NN(Z`7^GF-'FW\T3CCCGIG_XVPQ#[2-"Y&(0\XF-X`QD6<BS@
M)=O3```XSG.<^$``XQC'[,8QTYXQ^JP"^?9X4`"L/^W'A)_:>O/6OTWDDE\*
MP6E9F8+(*DDFBS2*HZ_8J@*!\```.@YG<YUYS>......................
M............................................................
M............................................................
M................................................>+["X/,;&D26
M(P&,/LRE*Y&\KT,=C38K>'M<DCS(XR1[-1-B$HY8LRW,32I5&!+`(?E$BSC&
M>G/T,GG@QH^[D.D<5RBK$**LP514T%68A5'Q+$`=2.>&<;%R<R88V)&\N0U:
M*BEF-`2:*H)-`"3TZ`$_`<I<&,"$$.1A+P(6,9&/`LA!C.<8R,6`!&/(0X_'
M/3&<]/V8SS(20"0"33X?T_MH/VGF.-%>149E12P!8UHH)^)M#-0?$VJ33X`G
MISTMIE'.[8@[<K[!)18&B00H]>']!,]@C55^9E(*B3UHY^YOJ>M&JN#6HRS"
MXL`/C4%+?1#58,-*18%D!>/'^ND^G<WE29\2[63';)C>+$[&,$:0RH>T\@RD
M"P-ZEM5%95*K>*%^>N0OF4FKGQ=C%JGR6C95823]L@@+22-H7+"A9F(?U]$M
M6I<>:1SV#SR'QQQSTS?\;3_J0H;_`-SO+_>&8\\9?5?_`#_G_P#0_P"VAYZR
M^F?^2,+_`*W_`'$O,@%C=QW2ZKK$>JCD-W-SW9\9*`?+('6,2L"YI/#B1#38
M&9-&NHHG-SX?D@E4$XP#EA*8!/U-R'P!SG%1KO!O*=IAC88V+;@L0%>:2''5
MRP!6PSR1WWU`2RM[$(E6('-BR/(-1C9IUK37[`(SM'&CRNJH`Q+K$KE.A%H:
MA<D!`Q('*AJO?G3B[81/K"JS8*`R^-U6W*W>RRT2I>DE$`;$(U)9ZZ80-T;T
M$ZCJ?(TAN"Q*FTK!W@SY?BY"SO%?(M;DQ8F=B2QR3R]J)B!VY)/358Y@3$Y%
MZ76N0MPN(Y+Q]G@972"53+;<4/ID445C=&U)$(#H2&4$7K4"X5C%-W8NW`L"
MH$EW$I90%`(X+QDJ0FB^.83JSD1PY7T1?Z3)+4)S.HW+TH/``0^O@#D6+)OI
M[YHAD#:[(K$.O0=?3?2/K^*:`](KS7TTNZ<K8_*_&96=8\_%/;0.Q[BVJK-8
M"6K:/50'K4%DK2]:S%/MXM/ZN@5?VK/=D:@CE76J8>57=DJIHT*(!+AIDP59
MWM$R0'JXZ<$)`\9P+*D(1"_=#G(L9QRKQ_%O),N;(QL;`S'RL5%>9!$]\:N5
M5"R6W"XNMHI4@W`6@D3SM]2N&-B<K'&O8])>XG;/6W[];?O>GX_>]/QZ<KBC
MMEZ`V7:7A^U_MV"W`Q,"I*A>'N`/J61-")8L"I$G3#<T`C41AP\(S<9"`8L@
MR#.!=,XZ<A;#4;74E!M,:?&:0$J)8VC+`&AH&`)H?C_K'V$<Y8&TUVT5Y-;-
M'/%&]C,C!ENM5J!AZ3Z6'520#45N!`H6O]Y-0K5LK--UOL15TUM<!C@4HKN.
MR1,XS!"-J),/</<F$C`G!K`E)*R(0E`"@].G3.>N.LC-\=W^NQ??;#!RX,*Y
M5[CPR+'<X+*MY4+<P5B%K4VMTZ&F/%W6IS9FQ\7)A?)21HV0.+PZEP5*$W5_
M#<CIZE4LM5Z\VEV;UZI:]R8V"V9;K8GL).VEO"NMX8PRZTK&;FM0G.4H'%Y@
ME81^7RE@;G4M./"12N2IDZH0<A*&+/X<FZ?P[R3>QI-KL8G'D:U))'C@C=JL
M*)).\:.18]UK&P*2U`#S%E>0:;#S%U\V0AV#.%[25DD!*W`M'&&=%M]1=PJ`
M4)8`CG*:Y[J:L;:!?RM?+IB=AN\3.&1+(D5AUC4_BHP'Y39S)ZZF+;'IW'B<
MJ0Y+"8L;B2Q&8R'&<BQG&,.]\6W_`(VZKN<9HD=597#))$ZN"R%)HF>)PZ@L
MMKFY*,*J03*P-G@;.,S8$JR(&(-*@@BA^!`-""K*:49&5U)5E)NBYK_)W-(A
M!`$0QB"```Y$,8LX"$(0XZB$(6>F`A#C'7.<_LXXY8(_=T;0YAD$SC(-@&N6
MN5=&F)YZHJZ$V=<+!#E9!II"I#))75,)F<69W%">2(M0G/6`/3F!R$T(!?AS
M<\?Z>^89&/'DC#,<<I(02R0P,Q%2:)-(C_`$CT]5]0J.O-<G\M\?@RVP>^9<
MI31EABEGM;U^AC"D@5Z1N2A(8!22*"O)0CN\NHLOI)SV,BM_UY)*78U#>BD$
MY8W4QT21MP=%Z=K1-4F:D:<Z01MX,7JRRA(UR1.I*$+^(6'&,YQ62>*^10[H
M>/9&'-%NF+`12#MLUMU2I>U2*HX#`E6*D*2>6J[/7/CRY<<\+8T)82,'4K&5
M`+!R#Z2H(+!J%1U-.1JP]TGMW2E+E9&]Q**?B"R0J%&6B:HG`U"4/&!!RY)D
MV#%+8+(<]?"H`4+'3/X?AGIDE\.\KAE:&379HD5K?X+D$^JEI`(<&TVE20W[
MI-16$/)-"ZB2++@DCM9KD8.H"&,.69+E0)W8RY8BU6O:B*S"O&_?K2UVJUVN
MYLV:I]=43!+1P1\L9+,&XZ(LTO*;"GHY@='D`\I$"].U'@/,P:(`2RQXR+..
MO(S>->1IG-JWU^:-FB7-"8)1*J@VEC';>%#>FI%*]/CR7-M]5C8XR\C*QX\4
MN4#M(BH7!(*7%@+@58%:U!4U'0\JJC=PM6MFG!Y:M>[[J^Y5T=1@<'TFNI6V
MRG#4D,/)3!-7'-9IZ<C.3E!>/"(7CQY@<YQT%C.<.?HMWJH5GV>'E8T+M:&E
MB>,%J5H+U'6G7_30T^!IPP=SJ=G*\.MR8<AXU4MVW#@!RP6K*2M38W2M1T)`
M#+7<WIMMK+K(8Q%["WG6M,?)P*!QXRQI0WQ9,\>D%@*D#>K=#2$J@\K]N2PC
M\SPXSGITQG.,6!J=KM2RZO&R,ED`N$4;R6UK2ZP&E:&E?C0\SYNPP-=&)MA/
M#!$S4#2.J`FA-`6(!-`33XT!Y4]*[!4EL=&%<THBT(=;$10N9C,IDD'>$[ZR
M@<RB"%1B0#BDR-,<8%.I`+J`0@]!8_'G'8:S9:F<8NUQY\;***P26-HVM855
MK7`-K#JII0CX<SP3P9,2SXSI)`P!#*0RD'J""*@@CJ".3#R#S+QQQQQQQQQQ
MQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ
MQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ
MQQQQQQQQSRS.PN`8N[;IGD(1"P7,IP,>0ASG``?2*P@>(><8Z!#XQXQUS^'7
M.,?^>>S/JP0/`<\$BI,%/]/]XB/^X$\\H?3&.1_-<1D5BJ+,6(!(4=F1:G^@
M7,JU/2I`^)',UW^0/V.TT+)G._&GD0*20U,F7RS8^EHPW&9^.&`,,5O5N5ZR
M(`&"$PG!,R<^M"0G^1$$:Y.#*<2@";1/I%Y\^7+!X;MW+9<CB/%D9@`Q-%3'
M9FI0UZ1%B;JB/H0@;>O._II&%;<>.(1*T@O@`]/K(6Z*@]`5C<X8V*I9@45+
M3VL[U_Z[+C__`!;87^QKOSHCQS_,.!_[V#^M7G>,W\)O_I/^[GD3<][\\+<<
M<<[CU';B6GJO_CJZS0^@711'[[VHV%LW7NM94C4@1KH@*3W#-E$CD3:KR$9B
M%URU)_;TJL&,&(%#@!46()I)?//<WC>/Y#]9,Y\]`^KQ$AED#`%&(QX1&CU(
M%"WJ((8,J,K+:21WY@[N;3_2K%CPBXVN4988;5D)+/DR*;60>F0(6:.K`EA5
M0UI'.VWI7I]5.D%`PJCJN9D!(VAK0*9]-,(DY4FM.PC$)`)18DT=`%`6/+_(
M'$`S/&>(?ID_EIRO`246`/1_D7D6T\HV;[3;2,\I%J+4V11W,RQ1C]U%+,:#
MJS,SL6=V8]M:+3XV@U,&IQ>L<*4)ZB]SU=R"6H78EJ5(6MH](`YI3:BP%FW1
M#NE%2F^,S=_H65T;9[:V,R5-BR27":US+X3+GYQ3C)&>_P`')ABYN+--+--4
M(G,)8C`@2E`SD/DF<_BY\5F)?!7,3(C)()B*I,CHM06"R&4.5#*H92Q5F>X<
M%TF-%Y`WD$-JSR8O9D%B^NC*R/?2X%0"C"I#KVZT[2UPW=OJQ*<J?N*]]U5;
M$UJNNH<IN>F%JL4Z?X;%T*U""%V8NEIZDM[5(C5K9DM;@U7X\#($,X><]1C'
MU[7\TUFPW/@WB>'I\?)R\]8)[DACDE(#QX0C]*!@"Y20"@N:RAJ%%*333XN-
MO=U)D/VZYD`JY*H:P1*H4M2.\LU"%]9K&&Z&/FV[-6N#!9M=]SACD-7J\]N_
M9S9N<K-7JXFL=6,D>?:L=SY6CD,I@T?<C2U3/"7IN5,@&-6G(2F%";<&$F><
M3U*@_4[9'7Y&CB4]KS/6X<:Y1!#/'*B0E5<T;\02"9W!D=?Q.B(I]<+P[5)+
M@;&/-QO_`(G*V,KQ),KMW(O2JR.LY:2KE+SW`&N]0`!6D:Z9;7D=FJ:7WVS=
MO'9Y=(-6+3)+MT+GI;<I.>[WK:6NZM8W4A&T10#0NEG*9@J.1-J,(_"8ZY6I
M0B"G*29'*\C\?D^I4<'FWC4,<4V0_:S(S*2(70!1)0W-VTC"W`$RF/MN(2Q=
MC%U&SP_"\Q_#LUV>XO-A@*H!CD8E<:]V'XQE$H0R-:U5!E4LL8NRNJ;S?MF=
MO;;;N`VFV-+OO-?I3/+IBH$0D>&N#SV;FL]=T9232J)(2Y=*QUL9')&F$'(@
M8>E2!P79$`UQS@&M:],;S/RW6^*8C=OQ;$9TA1GFH\:!ILB4@W%,C-[9+%51
M59HX_1%$MM]N<QO&O'LW?!(ALW59'!9F3O%8X4%0H9E6B*OI0-2K&,LSB]CM
M@ZWM>O\`J15KH\>*1WG=D4C]U[&6L]C]SG-G6Y9#6FEDC<Y3)%.!.+L2Q'N_
MMK<6,?E)D*4L(`XSD8A4GGNWGV/D61A`A=3@SR08T2@*D<4;E%M0,ZAG"*TA
M#,"W0&Q4`L/'M;%@X"3EFEV&0BO-,Z62RL:L+Q:K*$N*QQL*Q(`GV'F._OR4
M2ZU36$7[I>L_HZZVRT\E43=W>9,J4I$99M/R&0-L6?X-8A210W9ES$@6O"8_
M!*LPS.&T2]*7C'J<9!M7TLVN/FY<OA&]5LC2["(B-&8VPRQW2W(":('7N5L`
M<R]E@P"D-KWG>+/@X@\NU1=-S@K^Z`5EB9TO28!;GC1;G`N4)ZG!!HPS;:Y7
M.R;%T'35\QTGTK-;]:0VPT*/S,G90!E3$B=C6[)V0@R:)N4*1D9%X0^+)?7I
MC]G.L=M@C5[7)U@<R#'R)(KK;;NVY2ZTDE:TK:2:?"IYN>ORFS<"#-951IH4
M<J'$@4NH:@=?2X%:!UZ,.HZ'F%OO>7[:<@F>F_;*HV6.E>2[?:R<1^TK%:1K
M$;G%J*9W1H;Y8WM"Y*<E.PKDQ+BJ&I"29@9B!K.2&9`!;@7.Q/IUIH(L;/\`
M-L]!)BZN%C%&0&$F182M1:Y`CJI#%**S+)<!$W--\UV62F3K-!A-,LV?FH)#
M&2I]O&RF47J0ZU#`DH0;%<%@#0YL*)HFJ-::IAM)TG#&B!UO`VDAH8&!H("4
M'`2@X]4YN:KIZEW?G=3XE"Y<I$8J6*C!FFC$,6<YZ\VVVV.]V,NVVTK3["=K
MG=J"M`````%1$4!(XT"I&BJB*J*`-XQ\>#$@3&QD6/'C4*JJ*``=``!\`.1'
M3^GU>4=L?LO?]>X3L"?:1IJHZP8`W-921@'8-<`G#>OL%/@I1Z4MRF3'*$A*
M\DM,4$U2A&J,$8<I-%R?LO(]AM=)@:3,(:'7&81-1;K)C&;&8*'8(4-A=VM4
MA$"JH!CX^OQL7,R,V)0)\DH7-J@FQ;5!(`+`"I%Y8@LU#;11AO[%LXH6CZK[
M@YDJFM6U?E)W&]G@&@D4IC$87`AL0310MIR-.YN"5<8Q,A!BH*<7AR4#.3<`
MSXL#QSL[ZH:_;;B71S:^')RB^C@:7MK)(HG>6>X6J"L;M&(254+5;&IU!.E_
M3[*A7Q<['-:..27(R)97-J7'NO<[GTB@`I4]`JTZ!0!E*K"&:_R[5F];HIQH
M.-K#=F'/^Q3@S.S*TLR%P!85)1N/#5!8VY"D&C#)6*.)ERP*DQ2H&N5'F",Z
MC\(>L]KL=SB[#'P\N2N9IZX\3=6M$.1+(`+ZU"R.UH*@!:`K\:[MBKBRQ-DX
MQOAR:25#%E(9%4%>I`4JH/HHI)+=2Q)L:_QL"$Y7:4HPTE.G)-53:\#51I)!
M11JLT%N2T@!RHPL`1J3@)R0%X&9D0L%@"#&?"$.,;+]6I)'\]S5=F*HL`4$D
MA1V(FH/Z!<S-0=*DGXD\T_Z9@#PG"I_^[^OEY5G^1*W-Z_M'[-FKD*-8:V+*
MA<6TQ4F(4&-[ABY((CPN0C.`,219A&L.*P:7D(_+-&'KX1"QF?\`10G_`/HN
M)'4]M\;-N'V-;@Y#K4?`T=%<5^#*K#J`>6?FT<<OB>P65591C.14`T*BJGK]
MH(!!^((J.O,H6KR=.EUIUZ(2)DR-.72%4^4F1IR4B4G`H*Q#R`A,G`4007XA
M9Z!`$(<?^,<TGRQ%C\JV<:=$789`'^H3/3EEX_D39>AP<O(-V1+APNQH!5FC
M4L:``"I)-``!]@Y.O-?Y;\<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<
M<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<
M<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<\MOL&?\`;-J-_P"R37_;
M*9\]B?5[_(N3_P"9#_6KSS/]'_\`-,G_`+*3^LBYZCRE,G6)ST:P@E4D5$FI
ME2524`].I3G@$4>0>0:$11Q)Q0LA&`6,A$'.<9QTYX[YZ8YTW-!.\QB[]==R
M-!-G),$RZXO36TS!K]/G4S!0K8BK/$9R0QUHYGFFF&J[+C+&6$I$:/.3'Q&E
MSG.<K`9PH]!>4?3R+3[G7>3Z)&&I;(QVGC^(@:Y6>46J`F.:$D'I#T%Q4BWK
M?3^?8.;L<[1[)E@S()IDC)K:\<2M<S/]T,+'9KK!:5`+,&)Z/O/1_/+7'''.
MUVRT_8,@_P`>72'9JN&Q?(7+27;B?7[)(ZW$'G*54);KFER5[>0Y1B`N3D1E
M<6B5JSR\]$K<%2>/P@*$8#I'#V.#']7-QH=F\286RQH8ZN`:N,>*B`.RHUZ-
M(%C8@RR61*;G"MWQ@XN1)]-M3LX%+KKLXY4B@@,8HIYR]M:`LH-U"1T!ZUH#
MWFZ.N>O]B:@KF\:K?$TBKZT8FT3",.B8THS(D+JF":8A7`),-PC>&=7@Q&O2
MBSYJ1:0:09@)A8@X\V[?5Y>DVF1J,\`9F-*T;4-5)4TN5OWD;[R,.C*0PZ$<
M[OQYX<J!,G'8/!(H96!!!!%001T((Y]7^X8)&K6KJE7-R/\`J':4>GLKBC,E
M1*%81QVM?C0)6[NBD@(B6A"E4RYO(),/R$*A0HP6#.18SC&&+"R)L27.0+[:
M%D5B70&Z2ZP*I8,Y-C$V*UH4EJ#KSZTR+,L!N[C*Q'I8BBE0:L!:I]0H&(+=
M2H(5J=9.C]'*.WLW0_R`ZEN>#1YT/>[)I1D@%D+(XV+IA5LH7P:R3$DH@DB5
M)1.+0O:W0I"J5)B#@$+RR0$JP&DCR#/H3?>4[#Q3P_P_.UDKK5)S/$KVB>)4
MP"(Y11@RFLG;9D;MN2\='%>==#0ZOR#.\@P,E8O>22QH)+09(P<>%HVZ%7L$
MJ7A;@KE"#45YD`[)>UEA6%4=D:7;*N&`[;Z%3);2-A$+CAY=)C7S(I-;:YL0
M@2G!:AV0JFU)EOROP$7K`)4ZP8LY6A$+K_ZH:/'Q]P/)].&?QW;5GC>SMA9'
M)9T*!C86_BJM%4!S'&"(B>7GBFVR\I<G3;4K\YU\HC<CIW(V%89J"JJ9%K<@
M9BI4DA;@HAWO!M;</N&]C)U&VH1.6-MY,A"Z"2$B7>C`MJE;A#A8(&3L)2E8
M`G8+QGPX,Z"Z=<8SBP^GA*^'>4E20?91_P"U,D']HZ<JO*(XY?,_'EE56429
M9H0"*K'&RGK]JL`P/Q!`(ZCET/?;UVEFRW;$V)AT#;U;Q,8>BC=MLC*WI35J
M]Y+K.0(9)(&U`D)4$&*5Q\43K\D%AP:,PT(0@+&9D&.:[],]PNE\RQ)I688T
MS&%Z`$D2BU/CU`$O;8E>M`?B*@VOG>LR]QXKE8&`G<S'[95:A:VRHS=6(7[H
M;XG_`&\N'[86R,1VLT.UFMR)."56,ZK8M#Y@A3Y"$V/V%`FA'$YJPJTWC&:E
M&E?&HTPC`^F3D1Q!X<>6:#.8'G6DSM#Y3EX>>"6>4S(U00\<Q+HP8*JL:&U[
M5`6572@*D"Q\;VF-M]+CY>/,L[=I`["T'N!%+!T1F$;]:E*FVHZD4/+8N^[8
M66;MZ6/2470"E-T;9R&"ZZT?72`19D@G$SF<R8C7%,THLG%#$!IC"!8H-4#R
M!*G,P3@X8<&!\5Q]+,7);RV':+5-?@I)+/+50L<?:=3<S@BC5M(`OMN92MI=
M*/ZB&*7QB36L3[O,EBAA4"I>8R*Z)U954&PU=F`4=:,:(VIQA?<QU&I?5?7;
M1VF-7[;@M3:\5_!IS);LL261=[Q8,9;@,[L6QH60](0<PJRT@5)9I@C#,C.$
M'.<8#CKSBD\"\@V6QV^_R<S"GR,^:6..-+U$4K%U!-LK7*2P:K4I;0L:GEDJ
M;[608^LU>+BRXL&+$E[S/$"R@H51.W.U%"J:NY/J`JQ#'F+/N4F[84Q:7:G[
MHFW->P>%NNO%YR&LMGV2D7-ZF4.@];SN7HR8?+&YP59-=SBG.('NZ=9A0=Y`
M'4U&F!U$JP#.]^$KHMKA;WP'2Y"30Y,:R87N:1=R1H@LK%GM`:&58G15CNL2
M24D)$6&K^48N9!G:GRW,$>--B9';R3';(%AE:Q:R2"(E.I1C;6/O,Z@E?5VR
M6-\9I,RL\DCCJW/L>D#6WOC$^-"Q.XM+RS.R0E>UNK6X)##4JYN<4*@!Q!Q0
MA%FE#"(.<XSC///TD<D,C0S*R2HQ#*0000:$$'J"#T(/4'G9P((J/ARA$MPP
M%=<CU0B-W$JLR.5PP6L_,A"8XPIHADID;]%8ZM<%P<93)E3R[Q=P"G3BS@TP
MM(89C'AQUY(.%DK@KLF4##:5HP;EJ7559@%K>0JNA9@MHN4$U8`XQ-$9CCA@
M9U4,5^T*Q8*2/L#%6`K\;6I\#SKL]FW4O4_9"M^X0ZW=KQ15QO"WN/;71HJ4
M3RLH/+Y2FBRO$5-3(6:6NS.MD#2A+.<5)Z42145Y!YHS2<A,SD7.\/J5Y'Y)
MX^GC^!J\W,Q,8Z#%EDA21TC:9<G)%\L-0CN!%&IO4FD:J>B@#KWZ=ZW%;Q7L
MY<"=QY\A9`R"I];(RN"*DVBP@_8+3T%.9HH/$:ZUTUI:=-8_/")))*0U)3-C
M>VN(TI$L6UU%HNN@#','5K2"&6C2.:]C,3@,Z^$T\@T(,BR6/..GMS-E;?.R
MO(SCM%AY6;*U0&,2/(QE,2R-\2JL.A-UM&/QKS>L*+$PH8]5C,H]O!&H2ZK+
M&`40D$EJ&P@,?B5;J2#S'I_C:?\`4A0W_N=Y?[PS'FU?5?\`S_G_`/0_[:'F
MH_3/_)&%_P!;_N)>?3_(`G\+D?:UW>A##)6IUEM<'4$FG;`B4A.<8JHE5JUQ
M((ZG>20X_E#W=D-`J)!G/B$0,(^G06.MU]&,/+A^H&MRYHI$Q9L?8]MV5@DE
MF!E*]C$4:T]&M)M/0T/)WE^5BR^-[3&BDC;)AQ&[B!@62Y"5O4&JW#JM0*CJ
M.G,M6L><9ULU[SC.,XS1]3YQG&>N,XS`F#.,XSC\,XSCF@>5R1S>4;*:%E>)
M\_(*L"""#,Y!!'0@CJ".A'+#Q<$>,ZX'X^PQ_P"J3D@P:?0JS8X3+Z^E#+,8
MLI<Y"S)I!'EQ+DT*7.)R%TB<D1IER<0TZ@UEDK(K0G^`0L`4)C`=>H<\JLS"
MS-=D'$V$,L&4%4E)$9'`=0Z$JP!`9&5U-*,K!A4$'EVK*XN0@K_HZ\J_D7G+
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MPBC#LB\J!Y!EXNL[TB/DYTNUFQHT0`,0N3*HI\$';AC9JR,JFSUR"I;E25=W
M"+-FNP6EQX7&S6S2+9N)1AGJ"WIKK[`GI]OZVWVJ)=+S(I8UDP&WV%/1LH2.
MC6;@#>FJ[VYR/CZW*5P`@-]01!S?#<'%UVTC(BD\HQ+WDACG=(\6(31E9(DD
MA<Y2F&[J<E7C6:.]&F6C9M?O9\C(PRPE74Y4"=J22..^:5HC+ZFBF_#-@:Y?
M;(EZ-9):45J'FN^.U%$]P/9NDGM:?;]1V\[)*1T5:5$:BR)/`-P&2BJ&MM35
MLYDL-A+$[$5U-4.P@'(QW?%3N:W-T;/P69G):S/+W%\'\:VWAVIW2EL3+1#/
MLB&)+8?N<N'O0(S272A<.06!8T$O1NDT(&2;/S\39Y$4DCF"<K'C!DC9%F"*
M>@C99G1^Y<P;JBP3.72.C<H6E>YS8TX[:KXIS8MHSC<:-Z+/>S=DWRV1#7%C
MB].2"51>W9+52Q]BKXW1-DE#&M=ZR&V921J&2D].4:2!>(I0?@_&;.^G^MQO
M/L2&:*"'QW*V>-BQ8E^299U8XL4QCD]:H]9FE!GR8E+*UBE`D;5FH\G;9:B/
M'1Y)=N=4N0\D?M_OD.A"JS`&02(RD=HQ(UJR,I-.4;"NX5NPX2'4+6"P)0Z1
M^_ZIWU'JQOQ-F:$UHVF6FF=(1;=CT4&O$$K@HH6W1J_H!`A.RA8UI6E8@`0F
M"0>E`NP+&(^(^+R1;/>8D(?5S:=\G7Q&21C&414R'ELDN$N-,RA4>1XB2P82
M!&"Q,3R+=13X&JVK(F='F]C+E`"QR,\4[XZ1EEM8RJL4KVF-E+Q(%!D9$N/'
MW;&'928ZB,FL/U2KI!86R&KS%9YE@1*JS,2>F-G:*VUL"-H6(:.160>SR5ID
MNN8BG#(P(#4V0>$H2DD_!@:D?3C)T4>:WD2PRD:G*FAL>7T2P/CK<:K'=02]
M/OHU>O4=+*/RW"VN9B0Z68-&V6BR4M(:.3%R94_XBAOBHRM9*I0W*$92]':Y
M]ZN--^J-=/5TQ6Y;IOQBTO4;6WA):ZK:/M5<,"7XI:DV8V>2R`E9'V>*N,P0
M5DH2-WI6Y0CPH/3@,-\W)V"\_D?TU,6]D.#)BX>FESH<>"-Y6:9^XT,;M$C%
MFD$;R%G#.K!5)'IH3%PO-L?'UV(F>N1/LWU?NY6CC%JHD1<LYJBKW&4H@44O
M(4VAEKD#K?<M'M1JGLG9-9-5B4A/*=03^!OA,C2UT\/T,L]DI:)VPA=XR>2I
ML2"REC):+":E*(]>E%@_.1%JV\D83",:YF^(_IOR_7ZC8O!FX>1+`_H[JK)$
M\YC*/412(QL97$;=/^7*>C<VK"VB[&"<QI)#-`UC*]E5<PQR]"K.IH)5!-:7
M`TJ*$XL-&^[#:L0-C<)W?=K/L:P=B*@T"L;4F&I('1J6R[6<=EZU7H;"<FQW
MJQ3`:6C-?.=NQAR.CR25K69_0-!0LKAB.-*2D[EY']/L#9HV5X@D$.+KFSEV
M#EI^U",:4&-B)FEGD?LRQ1R>WC*&4&Q+`96TW1>39\."LVY[^1-+C8,D:A8%
M=FRWDB``0I&`9%N5GD6D)C5D65)&DO"CW?1TMF34PO\`"6B[I1'G[,!8L/R6
M"L;6WL]I6G55C6]7E-O)$@F;0]8FDGCE7.9`7!&C61-*M\H*IX)*$(X&O2_2
M7RK'*IE-B1RR&0QJ9&)DABGCQY,A2B,%C5Y!Z9"DY4,5A8T!NH_,L":6"+'@
MR9#D8\<JD"(`&6*::.-KI5/<98)!4`QAJ!I`#7D50'NVOKKM'K?B=UO:L7H?
M;;4/2F<PJ&($5.2KZ57-MS?5IUI#I!.)>W2QLE#A!I:C8&5.BRA+7+$@5&3W
M!J;3LJ"$L^;Z=P'QC99&%/C2[/5[/(1Y"9D,N/!CJ[JD94I?&];ZT]71))(Z
M,:[!\Q,NQQCFQ3Q8N;AXCHH02+%)D29"AI)4!`64K$D=Q!-RDQH>[;&?<]WF
MVFUBVYDD&JFXI5%(@HH?3^3PM(]U[2#_`*]P:T+IVQL"G9&\;%29RA9EXL5/
MO$%A&0B6,;D:>W.H^H1!R>F3&6'@7B_C.\\6;*VV-&V6,O(B+1R3C,=$PVE3
MVD7=&-+.DK(QCD"B2-*`C\1QP\F\BR=+LV+23KKXUPF-B1E$$L^0DK3,8Y)!
M$4C4>CUWA%1E+D\ODFO>'U+@-@3"OI`BM1.=&9O<U6,\JS&HPDAT^MC7]YK"
M/6K7,8<W6;-R]F=8X]6XSD8=)*EC\:4X$:82YC)+\P6I)]-/)'Q(,D=B^:""
M<QAF:2/'R5D>&=PJ,K*R1,Y2)I)U%`T0>JBYG\MU^/FY&$\<]^.K^H!+9'00
M$Q1#N7F0G)B1`RJKNUJL3RWBSN[I';;0:H$ZBEV2B4V9?G;J7VT^R&(5L2V0
MREMN[K6PP%=RU))Y4X//S*7L48="!J8L@>BFO/E#]Q3B-+,Q<:[Z?3ZE=A)Y
M1%$Q379[8Z"22IDQXU(R%,=%,<;,M%D=2SD71,BN.1<ORJ#($'R219*S89E)
M6H6++E1$4U=&25U8R+Z'"JAO"WQDW(=P'9*7->OFNEK:D74N6MUG[A:QU5B4
M4*=0-CYLR`VG;2*M)E%X6_VRRS"K`O2P*XXEO7C5(4Z-W3E^J5`3`4@%4>(:
M''^;['7>38@6?%UN1)9DC)B[,L5CAI$A9)J`5#I:Q*,UJ7V$6'DN;E8VJ6?7
M.XF?)QT!C[3.5DGCC8)W@8KBK$*7](:A)`KRTW6'O*,T:IJ)PG;EBLZ6;.P0
MJ91J_'6!P^M4<=99Y$-R(%J&JB:SP3J*M3K,6*0W3#U+NJCR`4<5IU*M4W&=
M21H";K?_`$Z;+W!R_%C$GCF9,#BB1I`PC?%.6I(/=94"I(BAY'EJE'J"':%K
M/)8T@6#;LWO@\JE@HM=DS/:$*%ZJ!(\-`PZ)(OXDI25QP)_=!F-47&GF%Q6%
M*"M>HO8G=W1VA&3(A7;R\%M>E<^I:#5G'(2IB\+CCV-,F<9BXD),K%QJMQ,4
M$&.*W!818*F0^`XVTU;Q:S'0[>3`U4D1OD`5L@2G(=[G*FX1EVH@"*+8TN!9
MXGZE&%DK/L,@C5H-D9"R(O\`Z?*BBB4!:DV!S&E#=+569;V"KN*\[DM]AO1S
M1V&TV'B&%[S[O5<DK'*"@$,@:*MHCMY0;9^%5^]N4=42AM>7PZ3C<U#>N02@
MGS#580N3CE,4!'SGE^%Z.;46Z](5S#JM:R35R&5\C)SG@>8W.MD;Q_NG'8A5
M0+$DA=F^0[O9G8URS((TS)HA!&D09_[E'EQI(S2.`\0[B71RJDDA5BPC!')M
MCW>\H<^!QJ2SBC;]A$H?:VH"S1Q0XRDU3&-@V)I"RKUA"YJM!XN*+U^4B71R
MI7E&B3/ZR.2%U<_2)$K2-4IP074CZ3;6?-7&PLW!D@>6=`Y]P&4P9*8S=R)8
M))!1I%=VB$T,:5+RCI7(_GFLQL.#+SXI8^[!CRFA0J@R(YI1ZF=+K1!(*!>X
MYL6.-V:T<KNYM/?2BE.W_:&OA6PU)N>T6S,)KYZJI-&M6DUXO$!L&D+LL%E8
MU26]BK$JF#34UR@+2J*"J=DIB).I.3+@!5]4Q'#PS0:5M[M==M_E^;CX.#/*
MLSMGC&OA9%O/M1%E-%ZR32*XVJ5HM;K/;;5H?ELV-+9C9>6J$@QF]7@F=`K-
M5:LZQVE6]1(4$W4,?0GN<WU$^VAI7M/]NEA;S6[=DF8*SM-GH"+N\//CC^G?
MIC%)M(5D='$WM04Y1Z3Q`;.(DM"@8G-YR(1"U$B.2B'CRO#=/+YSL?'I,N/5
M86.7:,SLD@)%I""02A"MK,R,9&;M@7!FN(@97D&QU'C^%L6QVV4DBPK,\#*!
MZ[4[D:T#2&1V';1$"M4U:,4K<W>U\6^[]PRBM)(O/7&@*^G&MMG;`KK:9(]!
MGJ;6E,(7+V>'$4A6RFT8O.(*W+8PS/692_BRRN3@-M`0`H20`C#ATNKU>O@\
M5G\HGCBS<F/,3']NS2J(49+QDS=EHW*R,##$.XBWARUQ"J;;.S9)=JFAA:6"
M27%>;O(%J.W)$EB=V.2)B;R7Z,R+3TB]6%H+3W0L:V;-7M2EX6I/MMVIK8]5
MH30#=2%101VGLYLJ2D;5&7*N-30@$5C:IY)+II(6ZD96ITA#BA.`V(2,#-(#
MN,G@D/D?C^%MM+CXVK+C+FR'GGF$:H'A[**9.X5B5&9HF*EC&:S3RM8QHLOR
MC)T>PEP]BDF;Z,81KBPUD+R+DF2J&4U']W+"AJH-M&H6Y+,R[V%"HH7=S_6U
M46_/Y31C70;V_P`&=4L8A3J^)+XO9OUY3,[2$3[(W9GFL(L%68F<VA];V@\S
M)8#$PSDIQ:K--B?3#;R;+$P\V?'APLJ:6,3K?(B]N)YE>@53)'+$O<C:*_TF
MC6R`Q\G8OF>JS<5LG&68VG&])4`D93K&A!N*&R5FCE%U4DBD6AH"VE/WN*/%
M=B'7!UU@W*C5XKYFT5X76TBA]#-[^FFDE98?)HBQ.?AV)4(&HV81J8X<&TY2
M<4E/1-+J;DT`6Q7DOA#],-O/KWVT>9K6UL<;.TBR2R*$0.7;\.%R;>VP(`+5
MH`#7F;9>5Z_5Y,>'-'.V7*UJ(%52[EX$"(97C5B>^IJ"5"K)<P,9'/FI[X&N
M#BY%M\!JVZ9P25<=156N>R?I4UL(VRX(1<]C,L\95HK-7J'!"AB5!28:AI5$
M-[V0N1@1J4J90<6$67!^E>\R,@8N7-CXTYQ9Y@KB4L##VP8V58^ESRHH<71T
M)D5F05..3R_6]S%]J#+B9.08N\"%B#4F"A6:@D9WA9%5*_821?$).*3][^IY
M(NI)?7VL^RC_`%]<#A,S2IQ+6F"541\(BU.6+<9%C0C$\FC9%II%362M'(3D
M<L>V$+*B(-4*!"-P2D429?I5DX>/E-F[+!]YC]H".$39![DDL<:QRB./O1%A
M(#$$AF:1J*5127%9C?4'!RD62/"SD5K2.ZL,-R-%/*)5:298S&$QY"SEU'04
MNZTE/N7;#6Y7D3T-DVL=HRU*V;#;I4]3SX;3"'7R8N5GU/:%:6A,`?!'R\X_
M(:Z3.B\V'(#VET]<B0C)/'DTTPL8!`I?#M1@9.3L\7>8\?=Q,&24=XY"=J2*
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MS"HY$\T2PIBB96W["GS=58,:7K7!T&J:(<!G3DMHT^#S%+RFP^/:_P`?V7C.
M?W,<R[W&C6<6S.DG9CF3W+`LHQD7LLJ1*5GF[O=<J5,2+7;?(WF+OL0PY*QZ
MJ9FBL,/<5I7B<P@!`TS%'1I9V+X\(A[:JURRN;1XW>^Y=C0S;6N%>U]YTIL9
MJ_L.X5W%H&[TEIT^V/8*?9*.5FY:5Q2=S!D@=BT:I;S5+DY+7I5&&M(M;VMR
M")P4>6T#6N6PY&I\:7.UN1AX&-+I,S$#RR]W+[:>U:8["6*,S)DT"!3%W?O!
M+5C=V-*4;3<8VMS(<_,G.WBSE2%$7&21O<+'[;&>1X#BM)Z[YS#W.V/5?8`I
ME2EM[;7>=F`TA9LJLQ)"JWV$/T-CMB(JQI]2.]MI(7015K2B=[!H42]ODU>P
M.QT.%R^)-\(C34WC"T''K7Q.0:%`76;3Q?7PZ63,PD@&QR,0;`1M+*3BX;3V
M1QPM18YI"&593.U_I*Q1F0AC:X6ZF7,3'V.1)2'.&%<(TC7(F]HDI>57!=`T
M@?L]@JK%HQZT()^/WI;1?\1?W1_.(?\`<;]RWTL^8_3M!\*]I_Y//MB\KZ>>
M[=/:?I;_`"7D^Y^X]/XOK_6?S?)7Z6\?_P#Z=^FNU-\A[-;>[^-_Z#O7=VRW
MN=SUU[7;NZ=GM_A\R?-MA^G_`'UX]W\S[5;5IV_F7M[:4I3M>BOWOWKK_5SI
M6=@S_MFU&_\`9)K_`+93/G=?U>_R+D_^9#_6KSIKZ/\`^:9/_92?UD7/4DYX
M[YZ8YX^D886>5;I1Z,2%`2ZL$CVA:6%\:U/C].Y,[Q:Z=O<T!_EB`9Y*Q$H&
M6/PBQGPBSTSC//T"1VCU8D3HZXX(_P!83ISQ]DX\.7YU)B9`NQY=LR,*D55L
M@AA4$$5!(J""/L/,P/?&[*S]H#,55^4&T.K_`*<S9W3IBP!$XO+M0\G<A`)(
MB,P7J,JE2B'O2\?@8WA09GJ:8%O5BPJ],:OZV^GGU,B\L"ZK;!8_(E0DL+53
M(H22T:*JK&X6A>):KT:2.V.L<6V_43P%-"#O-46.MDE-Z4_@ER2MI50!%7T"
MZA4V+5RW3KO<[8YU-ST6>QG:&*P[+^OZHZB[<O\`;I/8-\Q9VAM11.*3)R*;
M7"S+`,6*I&S2Z61)N-C*H@@24[^(?XS#P%B+R$><X\F>=:YME]3<](\S%P98
MU@D66>1HEN6#'H%=58]RIN7H.BDU!'/4O@65)B>!8,D6/-DDM,"D?;N`,\QN
M/=DC6WI0T8FI'2E2.+8*<<Z'DT@>]%*L[OFE<6E[LO?9-2D+IO6&UZ"R].63
M!KGJ(U==%B3)!7[HL,$#!F6E0G2^2044`@LLL.,;,N5C["#'Q_+YO$MM[=:+
M*^3DX^2X"JB+-D8Z(\J(H)`(N:1FDD=W9BTN`Y&"X^5:[:XN,&8F%/8F$E@!
MT1LANV`1=2(QJ6+%@Q8UE.E6(^JIS9-[2BB>\%<NU%FUFZU.HV(L.":^GO-=
MPUV7('DUCIRN6^QTU4P!E*D;0D<PI<LZX`EI'48A%#&5FIVL!V6OQ=+%G>*8
MVBQ9NX(8YIE,S`M:V3*(Q++((V[32*T;,@%?4JE<A9_?/M1J]JNU?','=#8A
M*(3=1$;*:/H_K%R-UZ&JU!CC5:DFO42]YOL%7-4=[>0RVX'TV3WRRV%%]7I)
M%+MD/GR=4@=9H@*?6UP2*F93*U(T8FI6WC(_``1>3D98IODV1+Y3K8=5EY7A
M\&+C!A!V)\U.Q=V;NVK.Z>I80IO1Q:S=+EB:/%KD?69V1L(-?NFGR7N</-C,
ME;57HAR[12T4-+E'H5A'1!75O5M6]H[>1W>&.ZE]WNA=@6B(I(-()%1$8H&*
M-EDQE&J`:4V60SR.<S!/(RC4112,W.,D",3I4O7/FI$QA4?4]W6^//XSEYOB
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M220G)"`$F.[X*/6W'F(3HO$#S#LI$*1/Y@L^`H`>@<:)-X5!+,\B;CQ^-&8D
M(N3,54$U"J7B9J+\!<S-0=6)J>;#%N=A'$L;ZS9R.J@%F]E<Q`H6-N2JU/Q-
MJJM?@`.G,6ZZEU-9V?-K9T6IKNRZ'N]HN1CU9T`JVB]7K"HF6/QI82A2=/2U
MM6/*8A%Y.,'B#E2VA3E!`+H62#\<YWC&$65B1:_R[/\`'=OB0%C&SYN1%D)=
M3T]](26C%";75B21ZJ(H&JSX6QQY,C)\=QMQK\G)>]P!@S0M(6):0Q2Y+%78
M&T]MXUZ+53;0W!TL>W5[:J?8NV]2.Z/M%LRC8UT:9;DN2KZ+P&OV!US_`%ED
MIZMH=;<;K6J6][QCHM-:VT+BK#D8#E8RAY+Y6[?!?/Q7U.KVGC>M\?9[O;09
M6059@:AI99DEFF8>G[\G;!12D:4%+N.>49OS'(U6RGSE%$=_9'M`K:PB`R0$
MOZEV'K>MK.45%6^/[\9)^@/N!_E-5']\^:K^AHOSO0_S,G]ARS^>9WY5L?VX
MG^+Y2,^VR;+4A<EKJR>VQO).8',FA4PRJ(RBDZ>>6!^:%H/`I0.;:MN\Y,I(
M'CIG'B#U`,.!!S@0<9QGQ?$9<*=<K"\@TL.4A]+IERHR]*=&6$$="1T/P/,<
MVVR,B)H,C3Y[P.I#*WLV5@>A!!RB"".A!Z'F,*'5E<.OR/,0TP_YFM::=PL.
M4ME)N=#:A["06$I5"Q2N/8ZV47C-95*H>Q'*59@\DB<5AF#!=<&8Q^[S?,GY
M9NYFR_*Y?%LS.*4$L.7-ANSD`%Y>S`4D/I!50J*E650$*JNNQIM\%$BT^/MX
M,89"NR.,&9.V&<F"(-E`PH5946PT18UM6\R,\K5%&LTI'+H5PVCN\BHO[84Z
M'F6YM;*83K?,+L?D\((6I(\SLX9+-'.O(LP-"!T5)T:5$Q`]*4=^Z/(P!'BO
MVD3;?)PGR\SQ`:O`5A'B1RY,>.2]#(SV6S5D8*SVS*MPJ%`9PW/#Q7P?=R0X
M.[.;FLAEF,N&92(P%"J?<A4!%P]"JR!R(C&$B$<&Z\ZM1K5!/.$VO4*[^=<$
M6.XG2*:)$Y6I\@;Y!-E)>2E,]7-\I"])OERX&`A4JBL%84@+`$P(L%@\-WNM
MLWD*QC<MX/.\4ERN9<X26?9"95E61H0:D*S$@EC=5F)B8.J.LADQ]=A[V""3
M*>=EC?!05=;&C`686QV_="T="%9'5E4B1D->2!K9-@<I81WKU]F[.)83%[6N
MV35SJ3)+%,JR#,LT9FZJ87ZQY+BL!BZH4^<59IK6VD+PK#,&%G`SX\#JIA')
MDX<T4WAD./@7F&*.;,6,2-VZ3.;C)-*K1*P::22[[DHDB5$6\;)RF>9VUVV+
M3Q+&Q#82M:ID/I=<A77^(U*-1#ZHPC%V:(]<M6E&I$145]KJG[^M:P(]Q5NQ
M<,1L.H;[&D+BO,`:O6M3/*3'M`SJ7`PH(U`DA9'GCQD0\9$(6<VVZVL?D.1[
MG<KX+/+8J@]_9(0%O_?CR$D-;S56<J"JLJJP),+6P#3X8U^MUNXBQ`]X7NXQ
MH;@U`6RR0I*U9!16JP8$.P/Y8>J#-9],3B@I;7?>T=Z^N:S5]O["+7.`:H.E
M@WC.O+B2:+*97/'!^/<VF/P9%"6\AM9VHM$UA+)QYA`\A!D.#6;+(U6WBW>-
MD>%^^A@[,=),J-$CME5PJ0M$H,HE/=<"][>K?B3]W)F>XV&//AYN!N9,+(I6
M._"4`"E0KID++1J>H,[`BJ@!?3ROX95EG5[6C344-E/^0<Q0-@8$\78&Y.T:
MA'NK%'T24M$W-;-*UHE,L;$[4B)`2D\E<`28H`0EY#C'3G'*R</-RFV&3'X$
MVP=G;N=S/^\Y8W-'WNS(5OZ&6*0L0K27L+CQQHWPX%Q<;7[Q<98>T%]Q`0J5
MK1:YA*L/@KJ0Z+1$95``OTUQO=NU?HRLJ!KO0GN.*H?5T721IJ<9'6=1N,C>
MC`&'+7202%>1=2(A:_R)X6*%RTTLDHLQ2H'D(`!S@.-.WGCTWD&WR-SF[KQY
M<G(D+E4R)0B_8J*#$S6HH"K<S.0`69FJQM,+8SZ_#BP<74[%<:&-4478IHJ@
M`=3EU/0?$\FO[\9)^@/N!_E-5']\^57Z&B_.]#_,R?V')/SS._*MC^W$_P`7
MQ]^,D_0'W`_RFJC^^?'Z&B_.]#_,R?V''SS._*MC^W$_Q?'WXR3]`?<#_*:J
M/[Y\?H:+\[T/\S)_8<?/,[\JV/[<3_%\??C)/T!]P/\`*:J/[Y\?H:+\[T/\
MS)_8<?/,[\JV/[<3_%\??C)/T!]P/\IJH_OGQ^AHOSO0_P`S)_8<?/,[\JV/
M[<3_`!?'WXR3]`?<#_*:J/[Y\?H:+\[T/\S)_8<?/,[\JV/[<3_%\??C)/T!
M]P/\IJH_OGQ^AHOSO0_S,G]AQ\\SORK8_MQ/\7Q]^,D_0'W`_P`IJH_OGQ^A
MHOSO0_S,G]AQ\\SORK8_MQ/\7Q]^,D_0'W`_RFJC^^?'Z&B_.]#_`#,G]AQ\
M\SORK8_MQ/\`%\??C)/T!]P/\IJH_OGQ^AHOSO0_S,G]AQ\\SORK8_MQ/\7Q
M]^,D_0'W`_RFJC^^?'Z&B_.]#_,R?V''SS._*MC^W$_Q?'WXR3]`?<#_`"FJ
MC^^?'Z&B_.]#_,R?V''SS._*MC^W$_Q?(.<KA@#S;J.\WOMM=Q%\L9L/:%S.
MK>XNPO$58GIA8WR,M$ICU;.6S"JM8_-$,=D[BA`]HF@AW](N/*RIR`P6,V"^
M-9"87R^/>^/KC$$&V6UV!(8AI!C"1E)`-K.1Z5Z45:1)<UIYAD2Z;8-*K*:U
MQ>I2XI</=T8(69D#`A7-Z@.`PT-=H46QPB05FR]GO8]HKB6O09'*J_:]2]:F
M^$2:0@6E.0'Z011):93"\O07$@"C"I2G,/P<`(_%XL8SS(VBVSYD>Q;R?5G8
M1):DISI^XBT86J_:N5:,PH"!1F_I/,;3PMCR8K:').+,]\B%,&QW)!+NON:,
MQ*J;F!-0#7H.?9ON.O&R=QJQTO;0[@(Y'!FQ.T5RD70:(ND+JM"FBY,)P&HJ
MU<]CU=<5*I41`KVU0HC;4UJ%2,TTHX9@3CL#R'3;(Z^75CR'1#$R'#34G*O,
M0YD'?E&,)9E$GK"RNZAPK`!E4C+\PG]V,SY5M.\$L`[F/8!6M1'[SMAOLO"7
MV^FZWIS<I;DI]"\R61HNT9LZCD$SE"J<3!]2ZKZY)WF5S5=&Y/#%LPDKH5:X
M%K[*%D/FSRU&N"H9JLQM=UJ41F2%1X#,8T6V6-85\GU8B2,(J^^GHJ*Z2J@'
M:H%$D4<@4=`\:.!<BD9%V<R,SIILX.[7,0,,%FM"7,?==3:`M3UM`'PZ<CQ4
MHU'7-3(Q+>Q];:QCC3$YQ>.,RK2+4U0U,$9>W12^/,=9&XVQ1I&IB=WM:<L5
M)"`%IU"HX9HP",$(690P?)%E>=?+<$32%;V^8Y-S6HL:W'MU:U%5%K6B*JCH
M`.09_9Y44<&3X]/)#"M(U:/`94'3H@.20HZ#HM!T']'*V66E1KC\9]P[/FR"
M[X5(F67PWUFIFM2KXE+(TSMD=CLHC/GVH/V&1,$?94:%$M2^4I2HTA))0PEE
M`"&+%HMM`)1#Y/JT$\;));G3CN(]Y='I%ZE<R2%E:H;N/4&YJSGV<TC(TFFS
MF:-KE)&&2K4*W+7*Z&TE:BAH2/@>46UJM2F,\*IE[(%NLZD#ZDE(%#7I)J>W
MG@DR`#N6AD034EC$F!?41;^O"2LQGU!>%JC`1XP<9XK"2#RN:-8I?,,-HD#!
M5.RRB%#$%@`4H`Q`+`?$@5Y#5\5(HX$\?R!#$X=%$>"%1P20RCW-%8$DAA0@
MDFO4\WWONKGHF=N_X4+J]OCL2?X#'T'V7ZK>B8H+*O</E$+9TOU)\ALB4D]V
M5>O;B`@1K/4F^<6/S!]8GRK>W._ZJUU\CJ[GW^15G2VQF/;]3)8EK&I6U:$6
MBF-TP)(8\>3QV9L>(-8IBP"J7FK6*<BBW'JU`*GJ:\JF)VO24"8YQ&(+V@=E
M(7&K-(3I;)CT3U/ULCC'8*9(A.;$J><-+/:J-!+"$S:I,3E@7EJ`@(,$7C&`
MBSC.+)T6VS9XLK,\GU<N3`U8W?.G9HS4&J,T1*&H!JI!J`?B.9X)X<7&?#Q=
M#DQX<M;XU3!5'N%K7*,D*U5Z&H-1T/3G!-<NUL8XJ\P5D[+U[,\(D8HV.0PY
MKTXU=;XJ_#AJDU;$!/,>26:2T.@HJL/&<VY/)'E":,0B?`+.<\SMK?('R8\U
M_*]><R$.(Y#L,DN@D6R0(W;N42)Z7"D7+Z6J.G,<!P\6*2#&\>GC@F`$BK'@
M*K@5H'`R0&`J:!J_$_TGE3IKDIY%)(_,4?:,V=22Z)19)!HK*DVJ^N1$DC,*
M;VIR8D$/C[X5:X'-FBR)D>%B,EO3&EI"TJHXH)>"S1A%'?0[23$EP)/)M6V#
M-*TLD9SIS')*Q4M(Z&*UI&*(6=@6)123Z13.,M5>&5='EB3'6V(VX58E(M*Q
MGW-46WTT6@IT^'(],4:D&D-"4WL?6V8EC[>UM#"F,TCU.&0R-+(\N$C96QH)
M%8N2VUO:)"[*EZ4DG`"TZU2:>6$)I@Q9E#`\B%]/+<`=PU;_`.0R?4;0M6_#
MZFU56IKZ0!\`.08\?5PR++%XW(LJ$%6$.O!4@U!!&14$'J"/@>O)%DET5%,9
M/*)M+^T?M!*IG-X8*N)I+I)JSKF^2>7UX,TD\<#E#\YVPJ=7^&"/3%CRUJS3
M4.1%ASY74..D?'TFWQ((L;$\HUD6-!,LT:)G9"K',MULJ*(@$D6][74!A<U#
MZC6QDSS,[2RZ3,:1@H)*X1)"->@).54A&]2@_=;J*'KRFA377(1<@)%V9+[$
M3+(ZUP^5%"T\U?R7)HDR`CA;+%Y`#-G>%YCK07#V@*5$IP8F3A:T>"P!PF)\
M&===Y"IB*^68`,$K214V&3^'(S.S2)^'Z'9I)&9UHQ:1R35FKBCR8XI!+%HL
MI91$(@0F""(A2D8(R:]L4%$^Z*"@Z<XK+QJODJ+$9[)ESY)@R`AJA).=+-5,
ME0]K3/ALG3-L6+^I'@CZ!/)3QN("4F"2P+AB/QC!N<CY\76^0*[2+Y7KQ([7
M,1L,FK,`JAF/;J2%1!4]:(H^"BF)3AK&(5\>G$(4J%$>!0*>Y4`>YI0]V6H^
M'XDG_&U=VWS"@TM31*C7/M';;32JX.].,HC4/LG7BD+,;6^7/,@=Y:]3'I/;
MID)I\N>)2_KG%2Y#$)8:L5FFY,\0\\^/JMR^RDW"^3:B/9RH%>2/+EB9E4*H
M4]N%/2`B=/AZ0?B.<YIH,G'&'DZ'*DQ0Y<(Z83J'8L6>ULDBXEV);XDLU3U/
M-;Y*]:),T12/R3LMWI(6&!E.A$&9'S3;5MV:(82^/J24/1,4;5]F*$4=*>)*
MWD.*H*,!.%"X@L\SQ&@"/'R+5;V'(ERX?*M<F5-;W'7/R`\E@M2]A'5K1T6X
MFT=!0<PR)@2P1XTOCLS8T-W;0Q8!5+C5K%.11;CU:@%3U/7GV1337%M5"7-W
M9COI`M&*?B&L1:=ZOI50Q6NA+:[2$)019Q9HA64V%!3/^<Y_K)`<%J_.!C&.
M'U6]DZOY5KF/X?QS\@_PFOB_Y?\`RW]<?_`WJ6AZ\68'=;(_3LW?>^YNU@7-
MW`5DJ?<5-X)#U/J!(-03SAVERU18#BE#%V1KB95!!#HE(/:=*-4FXXE,^1E5
M"WM.4:CL<D99#Q#EQ[2J!C.`J&PX:4S`B!B!GZVKWSK:_E>O*W(:'89)%8R&
MC/\`#^*,H9#\5(!6A`YF>7'EIW=!DM3N4JF":=ZO=I7)Z=VI[G_'4W5J>6K;
M)TY5]L-]5E45VX]K=5U]<3M%+G,=5ZGUQ`4T];FFO+!KN.1Q_D&N&WFL]PM:
M6&(+)<53/EKEZ)*0<<:2I2K$:@],9>:>*7&EF;?[K4[&.2!HT[F>[-$6='8J
M,G#RX"KE%[BO`Q:@*/&PNY5[''?)@$.OU&7BU="]B8BWB%&$"EH<V&51"_;=
M"DBD!.V"%8TNJ;)S7[S3E)U+?G;5W8VL.I**1EC99WL9KCKY:<K=)&Q1Y`P.
M-@*54OMYZPBETEPB\Y8J(R$X8AYP(8L8ZYHSI,O&S<G*TWD&GP(,B8OVX,V=
M%47,R)Z(5N$=Q"5'3[`*\M'R#D1Q+L--FY4L490/*F"S$.MDA_\`4`#N#HX4
M*K#I2G3EPL;W,S#6%IBL0[<F]$5C#`A(;&*.1ND::8V%E;4H?`F;VEG;+L2M
M[<A3@QT`426`L&/PQC'*F;PPY$SY&1OM&\[L69FRI69F8U+,3"222222:D]3
MR9%M\F")8(-1GI"BA55?9A54"@``RJ``=`!T`Z#E+V+LK#;@:T+';?:VW!M)
ME;%^'5M9[%USH6;M;>Z83GI,.2%ODUPN:1(OPD4F%><6`)GEF"#UZ"SC,C!\
M8S-7,<C6>1ZC'G*VEHLR:-BI()4E(02"0#2M*@'[!S!F9HV,0@V&CRYX0UP6
M1<)U#`$`@-E$5H2*_&A(^WD6N4CUA>4+HUO'95NYU;'PJ)$/;<Y:9:L+D+P1
M`$#@UP0ET2*K*-3N!4*;'96F:`G!'AM(4FEI_+`8/&99T^Z+!SY3K2ZWT/O\
MBH[C!Y*'M=.XX#/3[S`,U2*\Q8DT&!<,'0Y,`>EW;3!2ZVMM;<D5MJ:5^%33
MX\V:IRU17+GUT6]D>XECG*!-XY,XJM*-4E"Z1":71*]M0GU6;8XU#N)L>D1*
MQ/E0(SR51(#0=#`A%B5[3R:Q(_U?A61@VCYCE46I)-H[?2I9B:?:Q/VGGS(D
MQLMVDRM!D2R,@1B\>"Q*!@P4DY)JH8!@IZ!@#2HY,HMGXN)^0RK/;`W+^3MC
MRW2-ND6-?*,"^(I`SQ!]K]H>TKL&Y<+R79J@DG<F5,H"9@TAJ7J$@!!(.,`*
MH;Q7);'7$;R'3G$12JH<N:Q59Q(RA>S0!G`<@"A<!CU`/)B;;(C=I$T^>LCM
M<Q'LP68*%!8^ZJ2%`6IZV@#X`<A5"LU+;#U*IM[(-O-ZE8]LLE5J$.DNIZ0]
M5(XVN6N<=?U)I%C%F'O;"Y.2A0B5"SD]*>>884((ABSFV.%Y*46,^78/;52J
MCYCE4"L2Q4#MT`+$D@="22>O(TN1%/()IM%E/,&5@S)@DADNL()R:@I<UI^*
MW-2E3S3E;JP42`+7V6;ZCBU*[.TC:'N*Z?ZPQF11R6/:`#8X32+R!EL]$[1R
M:FI"2PX=T9I+@'))><&XR`/3$-9O0IC;RG6/"U+D?.G='`_=>-XBCJ?@5=64
M@D$$$CF1\[NS)D2:3,.1%=8Y7"N2X4:QO=56X=#:14?'E8?4ZE#893U>NG:1
MVPDL/U]01MNI!FF>N%%3<%6%1!I;V*-J82LE]S/;BQ.S4TM2<DM<2<%:+!(<
MB-$+\>8TTVXBGR<C'\GU44V87,YCS)HQ+??>)`D*A@P=P5(MH["E"1S#)-!*
MD44NAR7C@0I&&3!(1"H0JE<DVJ5`4@4!4`'ISX.MA:_/U@GVT^=F_81YM52^
MQR4*;-==0]9'&P5$FARI(NB,B/F:RT3I&:^Q9:@(.;58E.5"$TDL9(P"`'."
M:?=18`U<?E.M76!&00C/R!$$<LSJ(Q%9:[.Y9:48LQ()8U3309.4N=D:')DS
M4(MD9,%G6TU6USDEA:>HH>AZCG%2^;U+/IA*)W,NVIW')%))<C=TK@<Y-Y!K
M2T*7Z`@JQWD$&C.-I@QBM9HNKO`V<3]'4;6]80GGEX58PH/\SE!IMAC0X\$&
M_P#'E3%8&,B07>F7O!7?VM\D8E/<$<C/'<`;>@IS;,E=YG;5[:LZT;\:&@`6
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M2PB[5E20"3;4D`_8.<SM)C.,DZ;.]R%*AZ8=P4T)`;W50"56HK0T%?@.<,AM
M6D&NMWJFVSL_[)-U0R-_*E<AJI#J=K8DK=^E)#PTR$B2O4&3VH7&'1_)?V%"
MN`L/2F*`K$1!V!^826(/-]%MGSEV;^3ZL[)%HLISIS*HH102=J\"C,*`TH2/
MM/(W?A&%\L&AR?EO_P"*S![?WKOX?N;?O>KX?>Z_'G0;[)5BP*JNY]JI-[-F
M,<@,-;)5)D[G*Y:Z)F2/-ISM`94U-8'%V6C*1(`+W182G+&<,!?FFAQD6.O7
MGH+ZG:W/VWAN3B:V)YLJZ-@BBK$(ZLUH^+$`&BBK'X`$].=$_2[9Z_5^2M+L
M9D@A?&=`SFU;BR,`6/I6H4T+$"O2M2`?2G^_+2/]7>M?YV5S_P#8N>3_`-(>
M6_E>Q_EIO_!ST3^J?&/S'`_F(O\`Q\PM(M!.PZBW-SNH'8BEC):7.@6LWU?G
M9"N$]/MEHA7*77,M31="YI%AZ?#V?AQ`U*%9S64X%A,`1@H(20]E2>3?5>7Q
ME_&)M9DO#)"8FG;#R#D&(V^BX^C[JE"XC[K*[W.Q-1IZ:[Z;Q;L;^'-P5S>X
MTC`Y,+HSL;KZ2%RC*_K0Q-'0].J^GF7*Q-KNW5;<&E59V9LCJA.(!.&1='99
M$Y%;U:.+*^LKB5DE6A7)#I#D(@"#GQ`&'PF%&!",`@C"$6-`P?'O.-9EQY^!
MK]G%F1-<K+CS5!_^SJ#\"#4$$@@@D<VR;R/Q+)A;'R,_7/`ZE65IX2&!%"""
MU""/B.>;SW4]'ZJTUO@8-=KVK2^]=;'.=GJLWF$V'$YK)X04F4$F+Z]L)''W
MIS6I')@"N+`A<S@%D/2/H:#PGEJB"/7'A.WV^]T7N-SAY.)LL=DCE[L3Q!V9
M6*R1W*H(>QRRK7ML*,`K1E_,OEWCNOT^5WM'E1YFF:T7K+%(R.U_X;B-J]0A
M96**I!MZLI)[;?:C>Y5&_P#&\FC]`W62,<\:*QW*<(&[0Y:ZM\L13A-++),A
MQL:5,9A3N!]S)`I0I0I\^8:=D(,8%XO#GH;R&#!ROKECXVS6-M;)M-<LH>EA
MB9<82!Z]+2I(:O2E:\[W\`4O]/,=`6!,60*J2K"LTWW64AE/]!4@@]00>9B-
MI/GSQJC3[;5ES/\`45K2B;:U-M?65E>]/)@Y(MDD85')IJW&.!:J?120LA"T
MM_0N!I@5C>8>:,83@`.!UWXV\#;F6;:XQR->(,AIXTC52%[;FL9$3KCL)+`D
M@2V)B`04N0[?L7>;67ZZ8K+)9VI$(:I9EL->W,"C5];V.%0L_2EPJ'445B6[
MK9,3+C:+>J.?SRS+]:Y=&WB=R,Z:5X>59,IBPFZN9J>X+%;7#DB%K"=%5S2:
M2GPU&IE:3!(S/W>'D)QL/=(FO;%FPX(,;MM&B%)!V8WNE6AK*[,3/'(7:.0O
M`Y/;H/NO&=/KF&<'@S7>8&C*Y2LCA"C=M5*A;3'='6VWN!FN)V&@+2J'3K[,
MWJP[8E[H_3ZVHZYI+-LF=SDMA;H%=-J,<04,@IZ[N[Q'\N->&M.#1DG@)7ID
MR57G`C1C/->29/<EAQ>UC1A,>"2Z**.-F,^+CNP<QJH8![F4$50NX%!11)Q5
M1R^0IDJ24(8N!^&[BH1^@J2?6H_$4(;F4(>6U=J>;S64,*PFQ+%G4\DID#,6
MEF3"QKIG3X`I+<UKH?5V`S6*F*B4"E)L6&P%MJ9J\"AQ;BS5!^!@"2+&T_4G
M7XN)FAL"`P82SNB?A8T*LO;B8&,1?C3"Z]GED]*7I$%C964U/CDFSFPQD;9%
MBS9$4O&':2UP61B&+LBHZK&RQ(!:;V9I&8D4QJY9-O&=P>UV&5RBU2*3=I=M
M)$J]52"6V58T&L*;1J9UP\%PLQMEV<1VAW"I(T%P41L#4`U',6=Z5>!5CVDM
M+B5Y)@ZK]'8SZZ'&&P3&P)9C:D,T8:/(1F0??RXLAW@,T@-,::)4*?C7<G8;
MO[B2-WD8+)(*L.AJ5<*"%5:(K6J16H!#,75^5=LHX[#H=H9(;6,HM"85,^RS
M3*L+AJ:)RN2,#G5C9+[91J\["UX]MCJV.30SELY"MDG3,UF>%Q9U1"\P)>49
MXE-7H)=-\@KLH,9-C$<U\?(DL*R&/%!]K)$5H[=R9)X9IBPO08Z(PD]%5GR[
M5-R>R9SK0F("J*O1I,B59)`QC8M:J1K,H=!'!))-4.J5FWN*6E>T.KEJC^L2
M5Y7W$W!<;U4(&=0UM^'.NJ%4M$NDD27.+YY;9A+9#P:W,)Z4`QKE3<L6Y()-
MP4;D%9X5A:7(VRR>2.8=$S""24+>8VR$D57$?;D+%561D(4%)%1Z]*&9OLO(
MQ<6Z%#8JO(\MQ"Q+"O<#,JNDD@9PJF-.CH7#D#HU,[^3%=,='TU_U7-[BA2_
M"2II?$`5[)I_7TA6-=@SRNDCP1)&:)J&B2KU3;"'1Q`-O4ASZ0T9I@B<*"2Q
ME2_",".+S>'4;B*)XA)+',CJDJ_AJY8`T<5#)T>,U(!`8JQKDVTV5-HILC4W
M#-;'9H:BQKV7\.JR!;34BJR`4/1@*'E=;K%.U3Z;#10JQ+40.,=GFOS>@G*2
M=2M?9!T<5WW72:6F.,Q1J3)$_D_3]6Y!6FJAJ,GH0#$IR;T&+,#Q!#F^2+=#
M!/,\.6RQ2(G:>48L[1J4]*`=P+:!:%-+;:"C>^X77K[4R!_=8M2EUUGN8>YU
M'6WMW7_99==TKSG-O7Q^:9UK,F?WZ;Q#71PFL]S>4K@4AE\16H7%!7CHJJ=I
MEDK@:UKE,=@+[*,*`*CB52<E2[%-J(\0BU62QQ]!CK/B9_8$<NV["+#$T0E9
MPTJ=UH@:CNQH/L5F$;2.H%AD3)L4GDGQXQ*T>$SN)`JO<U8GM'=1@85!]5_0
MEUC174M:\0L;U:[_`-L`2^];)M*I;*>H4\M`;:;P.<:N*+-KC9:Y@IZ=K$[,
MD1.1$X/AIS$M<"%"8KU2HTXM>0$)B@K%UGX^NF^H)B\:QX<O7KDJPA5E$4O;
M57G1&DJHB9EE"-U6RA0$6CD+%789OCBC,ED@SY(R5D*D21U8F!I46T&55[9G
MB%(V<.E.V:<E?2N2W4L9-AE>RR"1,UBP2XP05]<U:Y\/K>8M$)I:ISR[9IAF
M7+5K?'*[LTUR4O>6Y"67E`Z*5B,_QGIABS5^6)I%RL=_'[/E<F,707!I4#Y$
M[=K(IU$T((AJU.['''.H$<J<GZQL]UF;8*4?OL$%P8=M0JJPHBVB2TRV$R%"
MY4O46)%VE6P=PSB];PAEQ(Y,GCUJQR)[4:TB>B&T]*RTW*3U<`5U]E8RA`2S
M+H\;%FMV]N<@)W<1[\L$:5U(-R&]\STFEPM+KLK2E&R,>_#S;1(![J.DI?\`
M$`+ES))&&3T!(%%J54O'U61MILC)&RBCCQS*3!1[G,0)6L@`M4M:)%`8D+(%
M8!D):I*UV,A%;7!N"UVE8LLR4EN]Q<8TVO1L[E;5#*WANMT#FTM>&E)Y#JW1
M"O6MW:7\Q0>GP0BRZY&GQG*@117*+(TN=FZ_6386.+),:PN`JAY6S<B-59R0
M&EH46A-XB56($:W"1#-CP9,ZR2O?).**Y-`1!&2L((%4M0R&RX7F7K<&"WZ+
MW1I<X>M>B7+(&-PC2ET*=TJI8WY`TJVL:L#DG6I1)W!#D*,S!H#2Q%G%?@(.
M0BQCIJG+/F+R"O%@2'L^UL[S"U+AAMI2;76N!2NW2GZ69N:)SJ1JF$A_E1CL
MNRKDF']@?5YPS4ZD(B@EDB3'%^FP,OG8>Q.,/J=EKIL7&GUR[7(6''*Q1Q/`
MLCJD8$BA$)A`"LRWAZ/UE^-%F8Q;1#&&5)BS61!9KBSK(&2RXN29+GM5U9B9
M0Q0GU5Y.FF3QL0XH-@2K]8)(VVI%)\VPDU2[.KPHK2P7**UO%R`VE3+2N<EJ
M*(UG:!QY3H)K2"*]M=#UJ4WJ:1D8J+R>#40S8KZ2:*7`EQ>X%5&22$M//6#(
MN9BTT0HM]Q#Q=HBHZF=K\C(G20943131S,E":A@M+)$:@!61"KT6MC%HV-Z,
M!%VATN3/3%4C]:5Q7X[[1R&NW6,W_4\_6SHR*1VY%JP4REB1?`E#-\%JE9#U
M49=6^+>@]I3.D;SXP>X^(E3RX\P@2+/V.+IXL(^-0YO]WFC[)9X8P8HBDJF^
M8O&\4F2H+E9B&E6)R0:_538$@3(26?W,C.I25YP1(X$C(89B"A"I?&EBVQ5:
M("-R6RB\T'E_QQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ
MQQQQQQQQQS'?W3DJ1JT9V9M45JV/4K_2^O\`>T\KU_KVXYE2P_JH&J92T5H-
MU>X/(HJZR)23,'%*6U,ZA68@7.QY`1I5)V$X0[5X4&D\HP<00Q3QS942.KQ)
M,#$77N^F174>BI+@!D`)#**UUWRI9%\?S<B.66)XL.9EL<QF]5O1KTHX*LM`
M`X5@S!U<4IU[9CW.I+$=*]EZ2K%ROEKG!6N4&L]5LM:>Z1KW:[+83OK53;T=
M(Z2ALWD#S<8J8F4J;\$I7!J>%"$N2ORP0"TN%04Y?>.O\&P!Y1B;+/;#=XII
MX_9)@`PVQS3(%R64=GO0AA>)H@6:+ML)"K.=+WOD&UU>/G08F/D0X0#.,ULB
M^DI@$RA(IE>D3R`0*$(C#/;&5D(7E^L^[X\[5/4@:JNU]K&&-T+VDKFCY+(M
MB]@H_&CV^,R"^F>FWUZLF!Q%M=9U0:5V2.8G9KD3FE>V=.UISUGIW#)&$9VJ
M:_Z5Z;M=W.V&3DNV"TUF'CEZ,8F=#%*S&+)HPH(`T,DP(]<-UPMYO,=GC9$G
MO==[?6)/8L\DP"LONHL<LRV`Q`K(95+FC*IMN6K",VSO#2IFW,I2P)W$RH+4
M%]Z\:N0R:U#-=C<-#+2<SM'<[82F%M[1%O<H23'K*CR^*QAC?1NAA<7]1!SD
M;G@>`'A*'*?Z:XQ\3V.%!,DNVU^?(ZR)`LC3HF'%(V.9(Y'[;+(Q3MW24F#H
MRK(I7D%?-8D\@QU-'QLS%PA:LR@1/-)/1UCD[<CE@\):V)6$-)'"@(K2LN[Z
M4B?QQ=NA.MK!$W&37%KM!A.EN6TK;8]!FJW]G;`H"10.]#6:`84TIL.R-M<*
M7_XT++^!!'51CN:8J+090+:^3Z1)AR2+E9S3K'B32CL17"<ICPS1R8;&3^\X
MK&=5$UL5[!8U53*)$EOYKD')?%6"&*5,[&A_$E-UDV3+":Q]M2LQCB[R1W,.
MS()KF5;'G#5CO)(-IK<UDJY@UY-C!%_4C&+>>)*[79#<BCBM_+L`EUC-;Q=<
MQ,TAO--`W>$`2R)<V%(3F3*S)BM&4`K'FT7D/TY_3VLS,^?-$LV-.(UCC@D:
MH)CHTS@E,8LD@=%DJ'%`CL6')&K\T;9YNNQ%Q@JYV,\QD[RE$MN_#0E5,\JE
M:3(H4PUJ;E5B.%OMOF>QEB[A-CA=^R5=3:O+\@FGFJU5TI?5CT8P&26P-<J5
MN!)<\Y2U.^160SLJ,J[&DTD7A4+C$P8C&E)>$QAZ<H0,VH>#7X>J0XF)[!\2
M3.S)IH(9I'CBR\J!HXWG0JBRK#%!$@I7*84D4R$#YOW>8SE%R1LO<QXF,JY&
M5%%(SQ1R]UEQV7T17RM(U"2D++>"`%H62O=>G=Q6F]/:[[@%XHU4.H:SJPV3
MASUM!+Y'8,[4S&GD+'3\=@$="L=53+=-;HHXZS^0V(6E2/C7D\CUKLI-6EE(
MLT4-OB&1Y1L]7B^O*CDQ!'"J1`+E%YS.:7-`PD7%B@[JN4`9%LBDD,B+,QY]
MK%X[@9K2/C8DG=?NAIUD`6&,MUL=_P"*\H>)U601M(JEHPU?PANDFO,'K#8B
MNK@V/F\>V"WEU\@-;0B\]A[HO5O=-9;0EC91Q:]*GM>=RGR!S!D>U]M(EJ8M
M*X)$V&Y$?_!2*BC\66IV<\_C>1BX?>P-9D2SS108V.R9,2=]RSPQ*&6-E&O$
M=[1RN3+'225:1-0Z1PP[1<C.;&S,_P#NT+R2/6.R2($M.>X8Y(U;.(=A;1%C
M4LOXL_W72+#(=P&B5I=D]HZ[+@S$9L=?*ELVGL^(T9`8!'XNN@=6P\RI,2EO
MI1J:)G+(TXRE<<YLSBB6IX8[ENP#BG/&<U&IV$F+X\6.%@SF9SB0(V-%)++(
MS=R>4R6M/?'')%CH$:*GN(Y866:`L;#-@;(\FAA@R,M)(D]Q+:[B)8A^%'`8
MZ"`B9^[*7</,.RZ@A6C,>*!)>2NW]6>YK+]6MVIC9$'B+K(K/H6,N^X]N1BU
MZB@D$H6PB'Z:YND;;-+'>%\^M"O7*61ZN5CHWMS8TA;C'D*1N5C;#]WPL,ZC
MR328_D&!BX^1(%@FE?"@E@E9\B%Z&!D2%>S%,L$N4D4S!F<1"1XT<52;-<C6
M[1]'F"7*:9VA5IQ(4_!Z&/M/E.RDQ2SQ06(QH4[2*">7A;2;:7'+M3-6)6JK
MO:?4^JI;L7I<Q[*W!8<EAD`F2/76Q&QX=[$D1$ZI>Q72=U<6W2ML86F2/3H@
MAQI!3WD"?`,#/PFKO'?'-/B>0;''AR,#9;>/#SO9X\,<V0!EPR(L*"*?'EQ\
MON1F5HD23*0JI=I"RI?<;3.R\G6X>9B`QX\F5BM(6E1*PR,MWKC8U(++14D0
M2-1094)AEMRUZO'<=FQVAKTV!D]E.*NX35E!7S$VN[G\N3*'>=T;,)36\TM#
M6%3$$M7LL6@\(B1$_D<H7+#)@%6[%F&&)V@H#:IE[[&\=0>1:3"@QH98P9X9
M7A2,*(IT$ZQ3&Z0L\K-B10QK'`JPBAODF)U;0)NYH])NLC(SIHW0))&'9@_<
MB<*TR,,=%CB"B;O,)YI7EM#R*L+OQ<OG&QB6G^[)6)-D6DUS*A%,;N6`R_&_
M%HF15'&W_2Y19BU'3=W8K=OLN0S"&/K*5*7:&^6R0L*V0(,X`0P]4*NQQVTC
M;7QO:LNL[6<KX\B'78OHLSE0>YQ;WB13&_97+*3SF,,]TLX"P6LNSV3XNT@Q
MY$]V*/BL)&92DF/<AC*Q&29OPY9[$CDC8UA21@DEF4.PM@=[_AW;FE.K.LB"
MR(9>@ZW<=LS;PD:*.V;1]>R6+P1Y/-7(D3[$TP9XG2.[P)T6%('1,C<&D*8+
M88):3@OKB/4^*09.ZQ]UELF5B/(F(,?UQ3.K2J*,1,#%41E?Q@61B1*U"W+7
M/VF^D76R:'&BE@RR&E>5_3&G;$@4F*\!I!<JRJ)(U<`4:]>6F[<3.?N7=RK^
MI(I8%A+H<5HH.T)G547W"MR@4+.XQW:&")'JSXY#(,Y*8S/[*C52GNZ@F..R
M5&@D#44H]2>,*<LHR_T*1XGTYR-N\,`E39NBS28$&5=7%!,+22HS1HS&,*ZE
MC#+(C*$,K/SCM/<S>38>)#)(D38>2S6RM':0T"K($`:.5DO-J2K90L_4H%--
M0KOY1*?U5`+0::YH.-)YEMLDU=7--D;>+8:I9FQ^A4"F<7NHA*7K@]R53`,9
MG1;:_97M32*.N)8`G#-*&::GL<CZ/9<6PR<&*;,EC@UHRQ(N$UCTNNA4F>WN
M/13C48^X#J`(W*H<+^7Q(D,[Q)'CO(%E$L\44D*LD3!VC8_=1IDCF5F22-BI
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MHMUL9T9()<F5GBBF=5*AI'6=6C@1CU85RRZQ`EHX^7`;00)[KP_<?:JD]E-N
M4:[4ZD;,O%2WR_9:[I#4<MV/D+63>L0J`RC'V5%UDTPB#URD2(%,;!'RT@T,
M_;BR/(6-F1!I_'<F&<ZG4[#!P95VN7#`$7'A$PQ0WM'D68(\W?R9FD*NSWPR
MXUR(8Y549L^&1MIF9^+-L)#K86E:-9IECGG=3+'!8M([8(UC],:-W1.G>+,K
M]R]O>^L#+@@5:)6ZS=CJHMJ<+Q594+#2U]VA2R9).[,1(79ZG$_153*(<IL)
M/1<(A[M)AH7%8)+E`U+TZ<`3UN,BU;Q'*&+D33308DN!`@R)C-#'*3'%55@3
MNJX094TL4+2(C2(62041'#7/E2&7$B@CER8\O(E$$0A>1*22_P#.8Q49AC1+
M+-8SK$X5@_J[;)84\6O7+=W"VO7>D]]IPI=:WUYMZM;NK6R=HI7(QV%:"F"I
MC:8B3&H>D<Y9*HF%,L4&=7*86*0RFN@G!R0I')0[/JE02'9QC[`^.-O=IJL?
MV\^9#/$\>*B+$BR`3,RJL8DBR7F1(L4RK'0.8DAACCY&;.P,?R%,1\X]V'!=
M9`\\8#MZ)%9H^Z"DL<:22-(N,%,;]9/2%YS.K&RNU39J=N-74;I+96QKHI.P
M^X/#ZZN=^L*.WU4Q4XK`VPI!4D,BT^LV:,.QMIQ9"_A;HDV9.C+\Y9<DXR%Q
MY02SO2V&\TWC$_DVKV6=G:N/5Y4.LDF@CBDQ7>.4QQY#-'BPR8N+(J!Y9E#P
MVJ;XDF9EDFS:S+VN3JLN!PPVL4V3&&#*55JL\(#/'>557C17DQR7M[ECQLK/
MC`8]Z-RZ]U4F<N8'BPKJUQ;+N[>`_KO9=L-CD\*Y'*ZQUA=MH*(!)K#M.!V$
M^!?[XE[H6L1MQJMJC1;<^,C@!M;!#RAW=O$/&MGY)%@;:,XFSDQ,Y5A3%$"]
MGO9$6)ENL6,R"V"U@[1"2;\*1)&EMOTG$WFTQL63+R)';`BR]=W#WBT:B3&@
M[@$[L3VQ,Z2/9D3WTME1(I9)7R;3W=_;=C[B5B5>RT0H<U:W3FWG_7.LG>SJ
M#0Y3JXU8]4M[7;<M5%[3MD671B9%K7!Y=DBQ,3)TL=:6XMI)(Z2$\_KO#\3\
M9R/"L;<MG(A&P"9<ABR"(UL9NTI7%D(-"BQLM(FFD89#6B`IM\>\VOSY\"?'
M*DX<LJ0B2%Y"$:$1O]Y`C2&66-U=V0-`#$]M[O&K/NO:KQV.)5L24L4)K>BE
M_IZX434V4,JMP<'A3W!(W7@;-3*6>ZW1G:Y0!EDH'/+>ZO3=%!/)`@@;Q0TY
M&0JGR^&:R+ZKQ^--;\HE0L!8X6P8K-;ZH1(R7(1>BMD6]3)[L,RQQY!,?$3M
MN\EPRNSWJI3M^]]OWJ_PKNU^)6G9OZ]OM>CGG-#Q@(A!P,)F`BSC`P8%@(\8
MSG&!AP,(!X"+'XXZXQGI^W&.>J`20"00:?#^C]E1^P\\H2(J2,BLKJ&(#"M&
M`/Q%P5J'XBY0:?$`].?G/O.''''''''''/3/_P`;;&`]I&A<8&$>/F-X9ZAP
M+&,9%;TP%D&?&$&?$7G/AS^'3KC\,YQTSGQC]5B3Y]GU!'6'_MX?Z/Z?C_OH
M>G/6OTW14\*P0K*XMD-16E3-(2/4`:J3:>E*@VEEHQSN<Z\YO'''''''''''
M''''''''''''''''''''''''''-DY>W>W+_=_1>T^B5>Z>Y>1[=[=Y!GK?7^
MJ_EO1>F\7F^9^YX.OB_#KQQS=%>5Y1?D^7Y/E@\KRO#Y7E>''E^7X/W?+\/3
MIT_#IQQS7QQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ
MQQQQQQQQQQQQQQQQQQQQQQQRR'>V%4I.H-2#7=]NV'3+>CVVUI=:ND=;-C&Z
M/+KL`CLQIQ1<:7D2&L+6:BV1UL<Q#YYBA`F1A\L/JU9*7)WBVKQ3)VN+-FOJ
ML>')KK9Q,LA("XY`[S"V6)K@HH*,30FU2:$4V[AQ)L>$9LLD,*YF.PL`-\@E
M3M(U4<A6ELJ5M/05<+=6][FJ\N>......6ZF?;+]Q9_J/IS]RGL$0Z^K]'\S
M]![/:WP[T'J?X'R7XE\Q\CT_]7]A]P\7]/\`'RW/SKY.G\7Y-?+2GW:UQN[6
MG6V[VWWO1?9;ZZ\KX/E?OY_;]CYG2/O6V]S[K=KN4]7W;K+OW:TZ<G*0^P>P
M/GRSV?XM[.Y_)?D/HO8/8/1'^\^^>Y?T[V?V[S/4^H_@>1XO'^[UY78WN/<1
M^SO]W>MEE;[ZBVVWU774MIUK2G7D\TH;J6TZ\BJ3?0KY50?R?XM[W[J]?;OZ
MKS/C_P`F^!.GJO@OD_Z2^8_3#W7VWP?U/V'W7T/\I[CR?C?-_9YOM>Y[6U/=
M6_&SNK;W:>OL]_M75_"[_M[_`,7L\CP>S[,/MNW[:P=JREEMOILIZ:6?=M_=
MK3I7DB-'PKY'+O8/BWRWSV7Y[[1[3\C]5[25\=^7>B_J?G^Q>#T7K?WO2>'R
MOX?3D.;W?9B[_<]O:>U==;;<UW;KTI?=6WI==7K7G)/:^Y>SM^\L2^E+[:O9
M=^];6^RO2M]/MY%-X?:S[C6/W)?0#W;Y<9]&?KA].O<?GGHL^;],?GO\S\N]
MO_\`E[5_.>3^W]WDS7?/.S/\H]WV+1WNSW+;:-3N6=*4OI=TI=_IYQR_9]AO
M?]KVUC7=RVVVGJNNZ6T^]7I3X].3_P`JN2>6S"^SCZO6?XOMF^O7PU5]9_%]
M+/J]]/?8F;UOU/Z_ZS^&_&?;_-]U_D?0^G\7\+R^7R_J?Y?B6^_^5=[^[4[O
M:[US?P/W.Y?=_#]5UWVUY70_*??9'M_;_,J)W[;.[2W\/O4]5+?N7_N_=Z<C
M)%_QI_!*8]N^QGZ9?,E?V\>B^@?P3Z@^B+]?]&/(_P!/_,O;O#YWL?\`.^3T
M\7[O3F8_J_NY%?F7?L7O_P`>ZRC6]W[;;;K;^E+J=*\^/\H[4W=]MV*GO5LM
M^XMW<KT_A65N_<MKZ:<OFYK?++CCCCCCENNP7VR^&OON2^G/IO?Y-\&^HOH_
M;O7_`$ZE_P`X\_UW\A\:^F?N_O7N'](]O\7J_P`/+Y;ZKYU9/\G[M+(^YV_C
M3OQ=JE/5=W^U99Z[OATNY7Y7ROWF/[SL>_K)V;[;_N?B]NOJ^Y]^W]W[W2G+
MBN5'+#EO=A?;;\(<?G7T_P#I[]8XE\F\CT_Q?ZS_`%(CGQOYU[!_3_?_`*H>
MU^H]X_A>Y>1ZO][P\NL3Y[[U?;=[W_M)+:UN]O[=[K;_`-SV]UMO[O\`#ZV\
MJ<WY'[6?W_M?9=U>]?99W/P[.[=TN_A4OZTL^RWDMNGPKY1%?>OBWS7R)#\(
M]T]I^4>E],A^5_%?5_U;R/2>F]P])^[Y?E>=^[X.5R>[]M)VNY[.Y+Z767>K
MMWT]-?OV5Z_>I]O)\OM>[%W^WWKSV[J776-6RO6ZR^MO6RZO2O*>N'Z/_3&:
M?7_Z:_1GV8[ZA_6'XO\`3'X]YI7G_-/FO^E?9O.\'C]=_`\7AZ_CTYDU_P`Q
M]XGRKO>_ZV]J[N?=-UMGJ^[6M/W:UZ5YE>RWUTL_T_#G*UQ].?@T8^D?PKZ:
M>UD_#/IQ[%\&]E\0_3_&/C/]`]K\7B\'I?X77KT_\\QY?N_<O[_N>\N-_<NO
MN^VZ[U5_IKUYBQO:]K^Y]OLWO]REMU[7_=Z77W7_`&WW5ZUY6O(W,_''''''
#/__9
`
end

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
